Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	May 31, 2024	May 31, 2023
Cash flows from operating activities:
Net income	$ 307,084	$ 289,942
Adjustments to reconcile net income to net cash provided by operating activities:
Equity in income of unconsolidated joint ventures	(13,269)	(5,938)
Distributions of earnings from unconsolidated joint ventures	7,533	12,172
Amortization of debt issuance costs and premiums	1,729	1,673
Depreciation and amortization	18,843	17,760
Deferred income taxes	5,000	10,600
Gain on sale of investment	(12,516)	0
Stock-based compensation	17,284	14,686
Inventory impairments and land option contract abandonments	2,508	9,576
Changes in assets and liabilities:
Receivables	(52)	(18,460)
Inventories	(195,291)	413,774
Accounts payable, accrued expenses and other liabilities	(40,632)	(132,245)
Other, net	(8,227)	(4,810)
Net cash provided by operating activities	89,994	608,730
Cash flows from investing activities:
Contributions to unconsolidated joint ventures	(10,937)	(17,713)
Return of investments in unconsolidated joint ventures	0	5,100
Proceeds from sale of investment	1,709	0
Purchases of property and equipment, net	(19,754)	(18,324)
Net cash used in investing activities	(28,982)	(30,937)
Cash flows from financing activities:
Borrowings under revolving credit facility	0	170,000
Repayments under revolving credit facility	0	(320,000)
Payments on mortgages and land contracts due to land sellers and other loans	(1,739)	(3,001)
Issuance of common stock under employee stock plans	9,272	5,010
Stock repurchases	(100,000)	(167,088)
Tax payments associated with stock-based compensation awards	(16,505)	(9,748)
Payments of cash dividends	(35,130)	(25,707)
Net cash used in financing activities	(144,102)	(350,534)
Net increase (decrease) in cash and cash equivalents	(83,090)	227,259
Cash and cash equivalents at beginning of period	727,342	330,198
Cash and cash equivalents at end of period	$ 644,252	$ 557,457